- Recent Funding
- Investors
- Van Lanschot Kempen
Van Lanschot Kempen portfolio
Van Lanschot Kempen has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is HealthifyMe's $30M Series B+ round in June 2023, which it led, alongside Chiratae Ventures, Khosla Ventures, LeapFrog Investments and 4 others. That company is in Health and bio.
What Van Lanschot Kempen invests in
- Health and bio · 1 · 100%
- Commerce and retail · 1 · 100%
- Consumer and social · 1 · 100%
How Van Lanschot Kempen invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $30M |
Van Lanschot Kempen portfolio companies
HHealthifyMe$30MSeries B+ · Jun 2023
| Company | Round with Van Lanschot Kempen | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $30M · lead | $175M | Oct 25, 2024 round |
Most frequent co-investors
KKhosla Ventures1 shared round · last Jun 7, 2023
BBlume Ventures1 shared round · last Jun 7, 2023
UUnilever Ventures1 shared round · last Jun 7, 2023
LLeapFrog Investments1 shared round · last Jun 7, 2023
CChiratae Ventures1 shared round · last Jun 7, 2023
HHealthQuad1 shared round · last Jun 7, 2023
FFinnfund1 shared round · last Jun 7, 2023
Similar investors
AAxiom Asia Private Capital1 company · 1 deal in 12 mo
BBeach Point Capital Management1 company · 1 deal in 12 mo
OOui Capital1 company · 1 deal in 12 mo
RRS Participaties1 company · 1 deal in 12 mo
SSelva Ventures1 company · 1 deal in 12 mo
TTheVentures1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Van Lanschot Kempen. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Van Lanschot Kempen, which is a subset of its real portfolio. API: /api/v1/investors/van-lanschot-kempen (get a free API key). More: the most active VC firms and new venture capital funds.